FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4849611000001104: Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    18597501000001118 Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    62793801000001110 Caelyx 50mg/25ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Is a Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has active ingredient Doxorubicin false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Is a Caelyx false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has specific active ingredient Doxorubicin hydrochloride false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has active ingredient Doxorubicin liposome false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has dispensed dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) 1 vial Is pack of False Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Inferred relationship Existential restriction modifier
    Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) 1 vial Has AMP False Caelyx 50mg/25ml solution for injection vials (Schering-Plough Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start